Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.

McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M.

J Child Adolesc Psychopharmacol. 2006 Jun;16(3):351-6.

PMID:
16768642
2.

OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder.

McBurnett K, Starr HL.

Expert Opin Pharmacother. 2011 Feb;12(2):315-24. doi: 10.1517/14656566.2011.546058. Review.

PMID:
21226641
3.

Pharmacological management of treatment-induced insomnia in ADHD.

Kratochvil CJ, Lake M, Pliszka SR, Walkup JT.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):499-501. Review. No abstract available.

PMID:
15843773
4.

Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.

Moen MD, Keam SJ.

CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000. Review.

PMID:
19958043
5.

A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.

Katzman MA, Sternat T.

CNS Drugs. 2014 Nov;28(11):1005-33. doi: 10.1007/s40263-014-0175-1. Review.

PMID:
25120227
6.

[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

Golubchik P, Sever J, Weizman A.

Harefuah. 2011 Oct;150(10):788-90, 814. Review. Hebrew.

PMID:
22111124
7.

Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.

Anderson VR, Scott LJ.

Drugs. 2006;66(8):1117-26. Review.

PMID:
16789796
8.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
10.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920
11.

An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.

Groenman AP, Schweren LJ, Dietrich A, Hoekstra PJ.

Expert Opin Drug Saf. 2017 Apr;16(4):455-464. doi: 10.1080/14740338.2017.1301928. Epub 2017 Mar 9. Review.

PMID:
28277842
12.

Managing stimulant medication for attention-deficit/hyperactivity disorder.

Wender EH.

Pediatr Rev. 2001 Jun;22(6):183-90. Review. No abstract available. Erratum in: Pediatr Rev 2001 Sep;22(9):292.

PMID:
11389305
13.

Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS).

Findling RL, Dinh S.

CNS Drugs. 2014 Mar;28(3):217-28. doi: 10.1007/s40263-014-0141-y. Review.

14.

WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Epstein T, Patsopoulos NA, Weiser M.

Cochrane Database Syst Rev. 2016 May 26;(5):CD005041. doi: 10.1002/14651858.CD005041.pub3. Review. No abstract available.

PMID:
27228176
15.

Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents.

Keating GM.

CNS Drugs. 2011 Apr;25(4):333-42. doi: 10.2165/11206730-000000000-00000. Review.

PMID:
21425884
16.

How high a dose of stimulant medication in adult attention deficit hyperactivity disorder?

Sachdev PS, Trollor JN.

Aust N Z J Psychiatry. 2000 Aug;34(4):645-50. Review.

PMID:
10954396
17.

From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.

Busard├▓ FP, Kyriakou C, Cipolloni L, Zaami S, Frati P.

Curr Neuropharmacol. 2016;14(1):17-27. Review.

18.
19.

ADHD, growth deficits, and relationships to psychostimulant use.

Joshi SV.

Pediatr Rev. 2002 Feb;23(2):67-8; discussion 67-8. Review. No abstract available.

PMID:
11826259
20.

Exposure to methylphenidate during infancy and adolescence in non-human animals and sensitization to abuse of psychostimulants later in life: a systematic review.

Jaboinski J, Cabral JC, Campos R, Barros DM.

Trends Psychiatry Psychother. 2015 Jul-Sep;37(3):107-17. doi: 10.1590/2237-6089-2014-0060. Review.

Supplemental Content

Support Center